Evidence map›Paper›PMID 39478562›Full record

ArticleMicrobiome2024

Eubacterium siraeum suppresses fat deposition via decreasing the tyrosine-mediated PI3K/AKT signaling pathway in high-fat diet-induced obesity.

Xueshuang Lai, Shuang Liu, Jian Miao, Ran Shen, Zhen Wang, Zhe Zhang, Huanfa Gong, Meng Li, Yuchun Pan, Qishan Wang

Abstract read
In one paragraph

Article in Microbiome, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueshuang LaiDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Shuang LiuDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Jian MiaoDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Ran ShenDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Zhen WangDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Zhe ZhangDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Huanfa GongDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China.
Meng LiJinan Laiwu Pig Industry Technology Research Institute Co., Ltd, Jinan, 271100, China.
Yuchun PanDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China. panyc@zju.edu.cn.
Qishan WangDepartment of Animal Science, College of Animal Sciences, Zhejiang University, Hangzhou, 310030, PR China. wangqishan@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity in humans can lead to chronic diseases such as diabetes and cardiovascular disease. Similarly, subcutaneous fat (SCF) in pigs affects feed utilization, and excessive SCF can reduce the feed efficiency of pigs. Therefore, identifying factors that suppress fat deposition is particularly important. Numerous studies have implicated the gut microbiome in pigs' fat deposition, but research into its suppression remains scarce. The Lulai black pig (LL) is a hybrid breed derived from the Laiwu pig (LW) and the Yorkshire pig, with lower levels of SCF compared to the LW. In this study, we focused on these breeds to identify microbiota that regulate fat deposition. The key questions were: Which microbial populations reduce fat in LL pigs compared to LW pigs, and what is the underlying regulatory mechanism?

resultsIn this study, we identified four different microbial strains, Eubacterium siraeum, Treponema bryantii, Clostridium sp. CAG:413, and Jeotgalibaca dankookensis, prevalent in both LW and LL pigs. Blood metabolome analysis revealed 49 differential metabolites, including tanshinone IIA and royal jelly acid, known for their anti-adipogenic properties. E. siraeum was strongly correlated with these metabolites, and its genes and metabolites were enriched in pathways linked to fatty acid degradation, glycerophospholipid, and glycerolipid metabolism. In vivo mouse experiments confirmed that E. siraeum metabolites curb weight gain, reduce SCF adipocyte size, increase the number of brown adipocytes, and regulate leptin, IL-6, and insulin secretion. Finally, we found that one important pathway through which E. siraeum inhibits fat deposition is by suppressing the phosphorylation of key proteins in the PI3K/AKT signaling pathway through the reduction of tyrosine.

conclusionsWe compared LW and LL pigs using fecal metagenomics, metabolomics, and blood metabolomics, identifying E. siraeum as a strain linked to fat deposition. Oral administration experiments in mice demonstrated that E. siraeum effectively inhibits fat accumulation, primarily through the suppression of the PI3K/AKT signaling pathway, a critical regulator of lipid metabolism. These findings provide a valuable theoretical basis for improving pork quality and offer insights relevant to the study of human obesity and related chronic metabolic diseases. Video Abstract.

Indexed as

EubacteriumGastrointestinal MicrobiomeObesitySignal TransductionAnimalsDiet, High-FatMaleMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSwinePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktEubacterium siraeumFat depositionLaiwu pigLulai black pig

Identifiers

PMID39478562
PMCPMC11526712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.